Aptamer Group plc (LON:APTA) announces the issuance of 30 million new shares at 0.2p each, raising £60,000 for working capital, subject to shareholder approval...
Aptamer Group plc (LON:APTA) reports a positive trading update for the year ending June 30, 2024, with a significant rise in sales and robust order book growth...
Aptamer Group plc updates on its partnership with Unilever to develop Optimer® binders for personal care, showing promising results for cosmetic applications...
Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...
Aptamer Group plc (LON:APTA) announces the issuance of 30 million new shares at 0.2p each, raising £60,000 for working capital, subject to shareholder approval...
Aptamer Group plc (LON:APTA) reports a positive trading update for the year ending June 30, 2024, with a significant rise in sales and robust order book growth...
Aptamer Group plc updates on its partnership with Unilever to develop Optimer® binders for personal care, showing promising results for cosmetic applications...
Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...
